Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis

被引:20
作者
Fukuta, D
Miyagawa, S
Yamada, M
Matsunami, K
Kurihara, T
Shirasu, A
Hattori, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Regenerat Med, Suita, Osaka 5650871, Japan
[2] Anim Engn Res Inst, Ibaraki, Japan
[3] Nipro Corp, Res & Dev Lab, Osaka, Japan
关键词
C1-INH; complement; xenograft;
D O I
10.1034/j.1399-3089.2003.01120.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present study was to assess the effect of various forms of the surface-bound form of the C1 esterase inhibitor (C1-INH-PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1-INH-PI, such as delta-1-99 amino acid (AA), delta-108-183AA loop, delta-whole loop, delta-exon5, delta-exon6 + 7, and delta-exon5 + 6 + 7, and that of DAF, the delta-short consensus repeat (SCR) 1-DAF were established. While all deletion mutants of C1-INH-PI except the delta-1-99AA were expressed in the cytoplasm but not on the cell surface, the delta-1-99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement-mediated xenogeneic cell lysis by delta-1-99AA was next tested, and compared with delta-SCR1 DAF. Both molecules blocked human complement-mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4-deposition and much less C3-deposition than the controls (approximately 85% suppression), whereas the delta-1-99AA showed approximately a 40% suppression in both C4- and C3-deposition. Consequently, both the delta-1-99AA C1-INH-PI and delta-SCR1 DAF molecules are quite effective in down-regulating the xenogeneic cell lysis, but accomplished this in different manners.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 46 条
[1]   DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
ASCH, AS ;
KINOSHITA, T ;
JAFFE, EA ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) :221-226
[2]   COXSACKIEVIRUS B3 ADAPTED TO GROWTH IN RD CELLS BINDS TO DECAY-ACCELERATING FACTOR (CD55) [J].
BERGELSON, JM ;
MOHANTY, JG ;
CROWELL, RL ;
JOHN, NFS ;
LUBLIN, DM ;
FINBERG, RW .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1903-1906
[3]  
BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730
[4]  
COUTINHO M, 1994, J IMMUNOL, V153, P3648
[5]  
COZZI E, 1994, TRANSPLANT P, V26, P1402
[6]   PREVENTION OF COMPLEMENT-MEDIATED ACTIVATION OF XENOGENEIC ENDOTHELIAL-CELLS IN AN IN-VITRO MODEL OF XENOGRAFT HYPERACUTE REJECTION BY C1 INHIBITOR [J].
DALMASSO, AP ;
PLATT, JL .
TRANSPLANTATION, 1993, 56 (05) :1171-1176
[7]   C1 INHIBITOR AND HEREDITARY ANGIONEUROTIC-EDEMA [J].
DAVIS, AE .
ANNUAL REVIEW OF IMMUNOLOGY, 1988, 6 :595-628
[8]   EXPRESSION OF A FUNCTIONAL HUMAN-COMPLEMENT INHIBITOR IN A TRANSGENIC PIG AS A MODEL FOR THE PREVENTION OF XENOGENEIC HYPERACUTE ORGAN REJECTION [J].
FODOR, WL ;
WILLIAMS, BL ;
MATIS, LA ;
MADRI, JA ;
ROLLINS, SA ;
KNIGHT, JW ;
VELANDER, W ;
SQUINTO, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11153-11157
[9]  
FRIEDL HP, 1989, AM J PATHOL, V135, P203
[10]   The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation [J].
Galili, U .
BIOCHIMIE, 2001, 83 (07) :557-563